INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
30/11/2025
Voltar para busca
Dado oficial do USPTO
FARMASINO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
72
Atualização mais recente
01/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
02/09/2014
Data de registro
09/01/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/10/2024
Última transação
01/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
CN
Examinador
VALLILLO,MELISSA C
Localização atual
Historical data usage
Descrição da marca
The trademark consists of the stylized wording "FarmaSino" and an arc which is above from letter "F" to "S".
Titulares e representantes
Titulares
FARMASINO CO., LTD.
FARMASINO PHARMACEUTICALS (JIANGSU)CO.,LTD.
FARMASINO; PHARMACEUTICALS (JIANGSU)CO.,LTD.
FARMASINO PHARMACEUTICALS (ANHUI)CO.,LTD.
FARMASINO; PHARMACEUTICALS (ANHUI)CO.,LTD.
Representantes
Neal Massand Ni, Wang & Massand, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
medicines for veterinary purposes for use in the treatment of skin disorder; pesticides; disinfectants for chemical toilets; dental mastics; chemical reagents for medical or veterinary purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
72 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/11/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
20/10/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
20/10/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/06/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/10/2024
71AG
REGISTERED-SEC.71 ACCEPTED
02/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/09/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
22/08/2024
ES71
TEAS SECTION 71 RECEIVED
31/01/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/01/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/07/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
21/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/07/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/01/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/12/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/07/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
17/04/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
17/04/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/04/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2018
GPNX
NOTIFICATION PROCESSED BY IB
17/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2017
PUBO
PUBLISHED FOR OPPOSITION
24/10/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/09/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/09/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
16/08/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
15/02/2017
ALIE
ASSIGNED TO LIE
15/02/2017
CNSL
LETTER OF SUSPENSION MAILED
03/08/2016
CNSL
SUSPENSION LETTER WRITTEN
02/08/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/07/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/07/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
14/07/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/07/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/06/2016
CNFR
FINAL REFUSAL MAILED
08/06/2016
CNFR
FINAL REFUSAL WRITTEN
08/06/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/05/2016
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/05/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2016
CNRT
NON-FINAL ACTION MAILED
23/02/2016
CNRT
NON-FINAL ACTION WRITTEN
22/02/2016
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/02/2016
ALIE
ASSIGNED TO LIE
26/01/2016
CNSL
LETTER OF SUSPENSION MAILED
08/07/2015
CNSL
SUSPENSION LETTER WRITTEN
07/07/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2015
RFNT
REFUSAL PROCESSED BY IB
08/01/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/12/2014
RFRR
REFUSAL PROCESSED BY MPU
23/12/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/12/2014
CNRT
NON-FINAL ACTION WRITTEN
22/12/2014
MAFR
APPLICATION FILING RECEIPT MAILED
20/12/2014
DOCK
ASSIGNED TO EXAMINER
16/12/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/12/2014
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
15/12/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/12/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FARMASINO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.